Carlyle files Vantive deal for EU foreign-subsidies review
US private-equity firm Carlyle has filed its plan to buy US drugmaker Baxter’s kidney care unit Vantive to the European Commission for foreign-subsidy approval. The watchdog has set a Dec. 20...To view the full article, register now.
Already a subscriber? Click here to view full article